15.5: Regulation of Gluconeogenesis

Search Fundamentals of Biochemistry

Learning Goals 

(Learning goals written by Claude, Sonnet 4.6, Anthropic)

Regulation of the Pyruvate-to-PEP Bypass

• Explain how pyruvate carboxylase is allosterically regulated by acetyl-CoA (activator) and ADP (inhibitor), and interpret these signals in terms of cellular energy and carbon availability — specifically how elevated acetyl-CoA reflects abundant pyruvate and high energy load, making increased oxaloacetate production appropriate.
• Describe the transcriptional and allosteric regulation of cytoplasmic PEPCK, explaining how elevated cAMP (via CREB), glucocorticoids, and thyroid hormone upregulate its expression while insulin signaling suppresses it, and how ADP allosterically inhibits the enzyme to prevent gluconeogenesis when cellular energy is insufficient.

Regulation of Fructose-1,6-Bisphosphatase and Integration of Gluconeogenic Control

• Distinguish between the competitive inhibition of fructose-1,6-bisphosphatase by fructose-2,6-bisphosphate — explaining its effect on K_m but not V_max — and its allosteric inhibition by AMP and ADP, and explain how these two mechanisms together ensure that gluconeogenesis is suppressed when energy charge is low or when glycolysis is being actively promoted.
• Integrate the regulation of all three gluconeogenic control enzymes (pyruvate carboxylase, PEPCK, and fructose-1,6-bisphosphatase) into a unified account of how hormonal signals (glucagon via cAMP/CREB/PKA and insulin) and local energy indicators (acetyl-CoA, ADP, AMP, and fructose-2,6-bisphosphate) coordinately activate or suppress gluconeogenesis in opposition to glycolysis.

Within the regulation of the gluconeogenic pathway, three of the major enzymatic steps are regulated. The first two are the pyruvate carboxykinase enzyme and the phosphoenolpyruvate carboxykinase (PEPCK). Recall that these two enzymes are required to convert pyruvate back into phosphoenolpyruvate via an oxaloacetate intermediate, as shown in Figure \(\PageIndex{1}\). The third enzyme in this pathway is fructose-1,6-bisphosphatase, which converts fructose-1,6-bisphosphate to fructose-6-phosphate. We will explore the regulation of these three enzymes in more detail.

Figure \(\PageIndex{1}\): Conversion of Pyruvate to Phosphoenolpyruvate during Gluconeogenesis. Image modified from Principles of Biochemistry (2019) Wikibooks

Pyruvate Carboxykinase

Pyruvatecarboxykinase is one of the primary regulatory points. It is primarily regulated by two allosteric effectors, acetyl-CoA and ADP, as shown in  Figure \(\PageIndex{2}\). When pyruvate enters the Krebs Cycle, it is first converted to acetyl-CoA. If abundant pyruvate is present, an ample supply of acetyl-CoA will also be available, indicating a high energy load for the cell. Acetyl-CoA can bind with pyruvate carboxylase and act as a protein activator, stimulating the production of oxaloacetate. ADP, on the other hand, is a low-energy indicator and an inhibitor of the enzyme. The next section will illustrate how oxaloacetate enters the cytoplasm.

Figure \(\PageIndex{2}\): Allosteric Regulation of Pyruvate Carboxykinase. Figure modified from Liu, Y., et al (2018) Nat Commun 9:1384

Phosphoenolpyruvate Carboxykinase

Cytoplasmic PEPCK is largely regulated at the transcriptional level. Increases in gene expression are seen in response to elevated cAMP levels, glucocorticoids, and thyroid hormone levels, as shown in Figure \(\PageIndex{3}\). The activated CREB transcription factor plays a role in this response. Alternatively, decreased gene expression is caused by insulin signaling. ADP also acts as an allosteric effector, reducing the protein's activity. This indicates that when energy is low, the cell cannot afford to use its reserves to remake glucose, so gluconeogenesis is inhibited.

Figure \(\PageIndex{3}\): Regulation of Phosphoenolpyruvate Carboxykinase at the Transcriptional and Allosteric Levels. Image from ProteinBoxBot

Fructose 1,6-Bisphosphatase

Fructose 1,6-bisphosphatase is both competitively and allosterically regulated, as shown in Figure \(\PageIndex{4}\). Fructose-2,6-bisphosphate is a competitive inhibitor of fructose-1,6-bisphosphate aldolase, reducing its overall activity. Competitive inhibitors bind within the active site and compete with the regular substrate for binding. Thus, they lower the overall Km of the reaction, making the enzyme less effective at lower substrate concentrations. However, the enzyme's Vmax remains unaffected throughout the process.

In addition to competitive inhibition, low-energy loads (AMP and ADP) also inhibit the enzyme. ADP and AMP bind allosterically to the enzyme, inhibiting its activity.

Figure \(\PageIndex{14}\): Regulation of Fructose 1,6-Bisphosphatase by Competitive Inhibition and Allosteric Effectors. Image from Jslipscomb

Summary

(Summary written by Claude, Sonnet 4.6, Anthropic)

This chapter describes the regulation of the three major enzymatic control points in gluconeogenesis — pyruvate carboxylase, PEPCK, and fructose-1,6-bisphosphatase — integrating allosteric, covalent, and transcriptional mechanisms to explain how the pathway is activated only when cellular energy is sufficient, and glucose is genuinely needed.

The first control point is pyruvate carboxylase (PC), which catalyzes the ATP-dependent carboxylation of pyruvate to oxaloacetate in the mitochondrial matrix and is regulated allosterically. Acetyl-CoA, the immediate product of pyruvate decarboxylation and the entry point to the TCA cycle, acts as a positive allosteric activator of PC. When acetyl-CoA is abundant — reflecting a high rate of pyruvate entry into the TCA cycle and a well-supplied energy state — activation of PC ensures that oxaloacetate is produced at a rate sufficient to support gluconeogenesis. This signal is logical: if the cell has plenty of pyruvate and is running the TCA cycle efficiently, it can afford to divert some carbon flux toward glucose synthesis. Conversely, ADP, a marker of low cellular energy charge, inhibits PC, preventing the cell from investing in the energetically expensive synthesis of glucose when ATP is scarce. Together, these two effectors make PC activity a direct sensor of both carbon supply and energy status.

The second control point, PEPCK, catalyzes the GTP-dependent decarboxylation and phosphorylation of oxaloacetate to phosphoenolpyruvate and is regulated primarily at the level of gene transcription. Its expression is upregulated by elevated intracellular cAMP — as occurs during glucagon signaling — through the activation of the CREB transcription factor, which binds cAMP response elements in the PEPCK gene promoter. Glucocorticoids and thyroid hormone also increase PEPCK transcription, reflecting the physiological contexts of stress and elevated metabolic rate in which gluconeogenesis is required. In contrast, insulin signaling suppresses PEPCK gene expression, ensuring that gluconeogenesis is downregulated in the fed state when glucose is already being supplied by the diet. At the protein level, ADP again acts as an allosteric inhibitor, providing a rapid, post-translational check on gluconeogenic flux when energy charge falls: even if PEPCK protein is present, low energy charge prevents it from operating efficiently. The transcriptional nature of PEPCK regulation means that its response to hormonal signals is slower than allosteric mechanisms but more sustained, appropriate for the long-term metabolic shifts that accompany fasting, stress, or hormonal changes.

The third control point, fructose-1,6-bisphosphatase (FBPase-1), is regulated by two mechanistically distinct inhibitory mechanisms that together enforce reciprocal control with PFK1 at the key branch point between glycolysis and gluconeogenesis. Fructose-2,6-bisphosphate — the same metabolite that activates PFK1 during the fed state — acts as a competitive inhibitor of FBPase-1, binding in the active site and raising the apparent K_m for the substrate fructose-1,6-bisphosphate without affecting V_max. This means that when fructose-2,6-bisphosphate levels are high (signaling the fed state and active PFK1), FBPase-1 is inhibited at physiological substrate concentrations, preventing futile cycling between glycolysis and gluconeogenesis. Simultaneously, AMP and ADP bind allosterically to FBPase-1 and reduce its activity, ensuring that gluconeogenesis is shut down when the energy charge is low — precisely the conditions under which glucose production would be energetically counterproductive.

Taken together, the regulation of these three enzymes illustrates the coherent logic of gluconeogenic control. Gluconeogenesis is activated only when: (1) carbon supply is adequate (reflected by acetyl-CoA activating pyruvate carboxylase), (2) energy charge is sufficient (reflected by the absence of ADP/AMP inhibition at all three enzymes), (3) hormonal signals indicate a genuine need for glucose export (reflected by glucagon-driven cAMP elevation and CREB-mediated PEPCK transcription), and (4) glycolytic signals are absent (reflected by low fructose-2,6-bisphosphate, relieving competitive inhibition of FBPase-1). Insulin simultaneously suppresses PEPCK transcription and promotes fructose-2,6-bisphosphate production, ensuring that the two opposing pathways of glycolysis and gluconeogenesis are never simultaneously active in the liver — a principle of reciprocal regulation that conserves ATP and maintains blood glucose homeostasis.